Emergence and Spread of Enterobacterales with Multiple Carbapenemases after COVID-19 Pandemic
Pathogens · 03.05.2023 · 12 (5) · 677
DOI: 10.3390/pathogens12050677 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 03.05.2023. Verfasst von Branka Bedenić und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, University of Zagreb School of Medicine, 10000 Zagreb, Croatia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Zagreb School of Medicine.
Abstract (Originalsprache)
Resistance to carbapenems in Enterobacterales has become a matter of the highest concern in the last decade. Recently, Enterobacterales harboring multiple carbapenemases were detected in three hospital centers in Croatia and in the outpatient setting, posing a serious therapeutic challenge for clinicians. In this study, we analyzed eight Klebsiella pneumoniae and two Enterobacter cloacae complex isolates with multiple carbapenemases, with regard to antibiotic susceptibility, β-lactamase production and plasmid content. The isolates demonstrated uniform resistance to amoxicillin/clavulanate, piperacillin/tazobactam, cefuroxime, ceftazidime, cefotaxime, ceftriaxone and ertapenem. Among novel β-lactam/inhibitor combinations, ceftazidime/avibactam exhibited moderate activity, with 50% of isolates susceptible. All isolates demonstrated resistance to imipenem/cilastatin/relebactam, and all but one to ceftolozane/tazobactam. Four isolates exhibited a multidrug-resistant phenotype (MDR), whereas six were allocated to an extensively drug-resistant phenotype (XDR). OKNV detected three combinations of carbapenemases: OXA-48+NDM (five isolates), OXA-48+VIM (three isolates) and OXA-48+KPC (two isolates). Inter-array testing identified a wide variety of resistance genes for β-lactam antibiotics: blaCTX-M-15, blaTEM, blaSHV, blaOXA-1, blaOXA-2, blaOXA-9, aminoglycosides: aac6, aad, rmt, arm and aph, fluoroquinolones: qnrA, qnrB and qnrS, sulphonamides: sul1 and sul2 and trimethoprim: dfrA5, dfrA7, dfrA14, dfrA17 and dfrA19. mcr genes were reported for the first time in Croatia. This study demonstrated the ability of K. pneumoniae and E. cloacae to acquire various resistance determinants under the selection pressure of antibiotics widely used during the COVID-19 pandemic. The novel inter-array method showed good correlation with OKNV and PCR, although some discrepancies were found.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Microbiology, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
- Clinical Department for Clinical and Molecular Microbiology, University Hospital Center Zagreb, 10000 Zagreb, Croatia.
- Institute for Hygiene, Microbiology and Environmental Medicine, Medical University Graz, 8010 Graz, Austria.
- Zagreb Health School, 10000 Zagreb, Croatia.
- Department of Microbiology, University Hospital Centre Split, 21000 Split, Croatia.
- Department of Microbiology, University Hospital Centre Osijek, 31000 Osijek, Croatia.
ORCID-Profile: Dijana Varda-Brkić, Andrea Grisold, Gernot Zarfel
Förderung
- University of Zagreb School of Medicine
Zitieren
APA
Bedenić, B., Luxner, J., Car, H., Sardelić, S., Bogdan, M., Varda-Brkić, D., Šuto, S., Grisold, A., Beader, N., & Zarfel, G. (2023). Emergence and Spread of Enterobacterales with Multiple Carbapenemases after COVID-19 Pandemic. Pathogens, 12(5), 677. https://doi.org/10.3390/pathogens12050677
Vancouver
Bedenić B, Luxner J, Car H, Sardelić S, Bogdan M, Varda-Brkić D, et al. Emergence and Spread of Enterobacterales with Multiple Carbapenemases after COVID-19 Pandemic. Pathogens. 2023;12(5):677. doi:10.3390/pathogens12050677
BibTeX
@article{Bedeni2023,
author = {Bedenić, Branka and Luxner, Josefa and Car, Haris and Sardelić, Sanda and Bogdan, Maja and Varda-Brkić, Dijana and Šuto, Sandra and Grisold, Andrea and Beader, Nataša and Zarfel, Gernot},
title = {Emergence and Spread of Enterobacterales with Multiple Carbapenemases after COVID-19 Pandemic},
journal = {Pathogens},
year = {2023},
volume = {12},
number = {5},
pages = {677},
doi = {10.3390/pathogens12050677}
}
EUVIMED